查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873537

肉毒桿菌：全球市场份额和排名、总收入和需求预测（2025-2031年）

Botulinum Toxins - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 101 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球肉毒桿菌毒素市场规模估计为 94.79 亿美元，预计到 2031 年将达到 158 亿美元，2025 年至 2031 年的复合年增长率为 7.7%。

本报告对近期有关肉毒桿菌素跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的关税调整和国际战略反制措施进行了全面评估。

肉毒桿菌毒素是由肉毒桿菌及其近缘种产生的神经毒性蛋白。它抑制神经肌肉接头处轴突末梢释放神经传导物质乙酰胆碱，导致弛缓性麻痹。感染这种细菌会引起肉毒中毒，这是一种被称为肉毒桿菌中毒的疾病。该毒素也被用于医药和化妆品商业性。

全球肉毒桿菌毒素市场的主要驱动力是美容手术需求的成长以及微创治疗接受度的提高。消费者对抗老龄化解决方案意识的增强，加上社群媒体和名人代言的影响，显着推动了肉毒桿菌毒素在美容领域的应用。此外，持续的临床研究和监管核准也促进了肉毒桿菌毒素治疗适应症的拓展，例如慢性偏头痛、痉挛和膀胱过动症，进一步推动了市场成长。

儘管需求强劲，肉毒桿菌市场仍面临诸多挑战，包括治疗费用高昂，尤其是在新兴经济体，可能会限制患者的用药途径。此外，严格的法规结构、仿单标示外用药的风险以及潜在的副作用（例如中和抗体引起的抗药性）也阻碍因素了市场扩张。来自其他美容和治疗方法的竞争，以及生物相似药的上市，也给现有品牌带来了定价和创新方面的压力。

北美是最大的消费地区，预计到2024年将占据约60%的市场。欧洲是第二大消费地区，占16%的市占率。全球领先的肉毒桿菌毒素生产商包括艾伯维（AbbVie）、高德美（Galderma）、益普生（Ipsen）、大元（Daewon）和LIBP。截至2024年，全球前五大公司约占94.0%的市占率。

本报告旨在按地区/国家、类型和应用对全球肉毒桿菌毒素市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

肉毒桿菌毒素市场规模、估算和预测以销售（千件）和收入（百万美元）为单位呈现，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定肉毒桿菌毒素业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • AbbVie
  • Ipsen
  • Medytox
  • LIBP
  • Merz Pharmaceuticals
  • Hugel
  • Daewoong
  • US World Meds
  • Revance
  • Galderma

按类型分類的细分市场

  • 50国际单位/管瓶
  • 100国际单位/管瓶
  • 其他的

应用领域

  • 医疗保健
  • 化妆品

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Botulinum Toxins was estimated to be worth US$ 9479 million in 2024 and is forecast to a readjusted size of US$ 15800 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Botulinum Toxins cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Botulinum Toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin also used commercially in medicine, cosmetics.

The global botulinum toxin market is driven primarily by the increasing demand for aesthetic procedures and the growing acceptance of minimally invasive treatments. Rising consumer awareness of anti-aging solutions, coupled with the influence of social media and celebrity endorsements, has significantly boosted the use of botulinum toxin in cosmetic applications. In addition, expanding therapeutic indications-such as for chronic migraine, spasticity, and overactive bladder-are further fueling market growth, supported by ongoing clinical research and regulatory approvals.

Despite strong demand, the botulinum toxin market faces challenges such as high treatment costs, especially in emerging economies, which can limit patient accessibility. Moreover, strict regulatory frameworks, risks of off-label use, and potential side effects-such as resistance due to neutralizing antibodies-pose constraints on market expansion. Competition from alternative aesthetic and therapeutic modalities, along with the entry of biosimilar products, also adds pricing and innovation pressure on established brands.

North America is the largest consumption place, with a revenue market share nearly 60% in 2024. Following North America, Europe is the second largest consumption place with the revenue market share of 16%. the global key manufacturers of Botulinum Toxin include AbbVie, Galderma, Ipsen, Daewoong, LIBP, etc. In 2024, the global top five players had a share approximately 94.0% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Botulinum Toxins, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Botulinum Toxins by region & country, by Type, and by Application.

The Botulinum Toxins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botulinum Toxins.

Market Segmentation

By Company

  • AbbVie
  • Ipsen
  • Medytox
  • LIBP
  • Merz Pharmaceuticals
  • Hugel
  • Daewoong
  • US World Meds
  • Revance
  • Galderma

Segment by Type

  • 50IU/Vial
  • 100IU/Vial
  • Other

Segment by Application

  • Medical
  • Cosmetic

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Botulinum Toxins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Botulinum Toxins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Botulinum Toxins in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Botulinum Toxins Product Introduction
  • 1.2 Global Botulinum Toxins Market Size Forecast
    • 1.2.1 Global Botulinum Toxins Sales Value (2020-2031)
    • 1.2.2 Global Botulinum Toxins Sales Volume (2020-2031)
    • 1.2.3 Global Botulinum Toxins Sales Price (2020-2031)
  • 1.3 Botulinum Toxins Market Trends & Drivers
    • 1.3.1 Botulinum Toxins Industry Trends
    • 1.3.2 Botulinum Toxins Market Drivers & Opportunity
    • 1.3.3 Botulinum Toxins Market Challenges
    • 1.3.4 Botulinum Toxins Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Botulinum Toxins Players Revenue Ranking (2024)
  • 2.2 Global Botulinum Toxins Revenue by Company (2020-2025)
  • 2.3 Global Botulinum Toxins Players Sales Volume Ranking (2024)
  • 2.4 Global Botulinum Toxins Sales Volume by Company Players (2020-2025)
  • 2.5 Global Botulinum Toxins Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Botulinum Toxins Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Botulinum Toxins Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Botulinum Toxins
  • 2.9 Botulinum Toxins Market Competitive Analysis
    • 2.9.1 Botulinum Toxins Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Botulinum Toxins Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botulinum Toxins as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 50IU/Vial
    • 3.1.2 100IU/Vial
    • 3.1.3 Other
  • 3.2 Global Botulinum Toxins Sales Value by Type
    • 3.2.1 Global Botulinum Toxins Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Botulinum Toxins Sales Value, by Type (2020-2031)
    • 3.2.3 Global Botulinum Toxins Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Botulinum Toxins Sales Volume by Type
    • 3.3.1 Global Botulinum Toxins Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Botulinum Toxins Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Botulinum Toxins Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Botulinum Toxins Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Medical
    • 4.1.2 Cosmetic
  • 4.2 Global Botulinum Toxins Sales Value by Application
    • 4.2.1 Global Botulinum Toxins Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Botulinum Toxins Sales Value, by Application (2020-2031)
    • 4.2.3 Global Botulinum Toxins Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Botulinum Toxins Sales Volume by Application
    • 4.3.1 Global Botulinum Toxins Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Botulinum Toxins Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Botulinum Toxins Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Botulinum Toxins Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Botulinum Toxins Sales Value by Region
    • 5.1.1 Global Botulinum Toxins Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Botulinum Toxins Sales Value by Region (2020-2025)
    • 5.1.3 Global Botulinum Toxins Sales Value by Region (2026-2031)
    • 5.1.4 Global Botulinum Toxins Sales Value by Region (%), (2020-2031)
  • 5.2 Global Botulinum Toxins Sales Volume by Region
    • 5.2.1 Global Botulinum Toxins Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Botulinum Toxins Sales Volume by Region (2020-2025)
    • 5.2.3 Global Botulinum Toxins Sales Volume by Region (2026-2031)
    • 5.2.4 Global Botulinum Toxins Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Botulinum Toxins Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Botulinum Toxins Sales Value, 2020-2031
    • 5.4.2 North America Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Botulinum Toxins Sales Value, 2020-2031
    • 5.5.2 Europe Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Botulinum Toxins Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Botulinum Toxins Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Botulinum Toxins Sales Value, 2020-2031
    • 5.7.2 South America Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Botulinum Toxins Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Botulinum Toxins Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Botulinum Toxins Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Botulinum Toxins Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Botulinum Toxins Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Botulinum Toxins Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Botulinum Toxins Sales Value, 2020-2031
    • 6.3.2 United States Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Botulinum Toxins Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Botulinum Toxins Sales Value, 2020-2031
    • 6.4.2 Europe Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Botulinum Toxins Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Botulinum Toxins Sales Value, 2020-2031
    • 6.5.2 China Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Botulinum Toxins Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Botulinum Toxins Sales Value, 2020-2031
    • 6.6.2 Japan Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Botulinum Toxins Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Botulinum Toxins Sales Value, 2020-2031
    • 6.7.2 South Korea Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Botulinum Toxins Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Botulinum Toxins Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Botulinum Toxins Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Botulinum Toxins Sales Value, 2020-2031
    • 6.9.2 India Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Botulinum Toxins Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 AbbVie
    • 7.1.1 AbbVie Company Information
    • 7.1.2 AbbVie Introduction and Business Overview
    • 7.1.3 AbbVie Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 AbbVie Botulinum Toxins Product Offerings
    • 7.1.5 AbbVie Recent Development
  • 7.2 Ipsen
    • 7.2.1 Ipsen Company Information
    • 7.2.2 Ipsen Introduction and Business Overview
    • 7.2.3 Ipsen Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Ipsen Botulinum Toxins Product Offerings
    • 7.2.5 Ipsen Recent Development
  • 7.3 Medytox
    • 7.3.1 Medytox Company Information
    • 7.3.2 Medytox Introduction and Business Overview
    • 7.3.3 Medytox Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medytox Botulinum Toxins Product Offerings
    • 7.3.5 Medytox Recent Development
  • 7.4 LIBP
    • 7.4.1 LIBP Company Information
    • 7.4.2 LIBP Introduction and Business Overview
    • 7.4.3 LIBP Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 LIBP Botulinum Toxins Product Offerings
    • 7.4.5 LIBP Recent Development
  • 7.5 Merz Pharmaceuticals
    • 7.5.1 Merz Pharmaceuticals Company Information
    • 7.5.2 Merz Pharmaceuticals Introduction and Business Overview
    • 7.5.3 Merz Pharmaceuticals Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Merz Pharmaceuticals Botulinum Toxins Product Offerings
    • 7.5.5 Merz Pharmaceuticals Recent Development
  • 7.6 Hugel
    • 7.6.1 Hugel Company Information
    • 7.6.2 Hugel Introduction and Business Overview
    • 7.6.3 Hugel Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Hugel Botulinum Toxins Product Offerings
    • 7.6.5 Hugel Recent Development
  • 7.7 Daewoong
    • 7.7.1 Daewoong Company Information
    • 7.7.2 Daewoong Introduction and Business Overview
    • 7.7.3 Daewoong Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Daewoong Botulinum Toxins Product Offerings
    • 7.7.5 Daewoong Recent Development
  • 7.8 US World Meds
    • 7.8.1 US World Meds Company Information
    • 7.8.2 US World Meds Introduction and Business Overview
    • 7.8.3 US World Meds Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 US World Meds Botulinum Toxins Product Offerings
    • 7.8.5 US World Meds Recent Development
  • 7.9 Revance
    • 7.9.1 Revance Company Information
    • 7.9.2 Revance Introduction and Business Overview
    • 7.9.3 Revance Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Revance Botulinum Toxins Product Offerings
    • 7.9.5 Revance Recent Development
  • 7.10 Galderma
    • 7.10.1 Galderma Company Information
    • 7.10.2 Galderma Introduction and Business Overview
    • 7.10.3 Galderma Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Galderma Botulinum Toxins Product Offerings
    • 7.10.5 Galderma Recent Development

8 Industry Chain Analysis

  • 8.1 Botulinum Toxins Industrial Chain
  • 8.2 Botulinum Toxins Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Botulinum Toxins Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Botulinum Toxins Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Botulinum Toxins Market Trends
  • Table 2. Botulinum Toxins Market Drivers & Opportunity
  • Table 3. Botulinum Toxins Market Challenges
  • Table 4. Botulinum Toxins Market Restraints
  • Table 5. Global Botulinum Toxins Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Botulinum Toxins Revenue Market Share by Company (2020-2025)
  • Table 7. Global Botulinum Toxins Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Botulinum Toxins Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Botulinum Toxins Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Botulinum Toxins Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Botulinum Toxins Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Botulinum Toxins
  • Table 13. Global Botulinum Toxins Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botulinum Toxins as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Botulinum Toxins Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Botulinum Toxins Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Botulinum Toxins Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Botulinum Toxins Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Botulinum Toxins Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Botulinum Toxins Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Botulinum Toxins Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Botulinum Toxins Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Botulinum Toxins Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Botulinum Toxins Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Botulinum Toxins Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Botulinum Toxins Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Botulinum Toxins Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Botulinum Toxins Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Botulinum Toxins Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Botulinum Toxins Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Botulinum Toxins Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Botulinum Toxins Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Botulinum Toxins Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Botulinum Toxins Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Botulinum Toxins Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Botulinum Toxins Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Botulinum Toxins Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Botulinum Toxins Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Botulinum Toxins Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Botulinum Toxins Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Botulinum Toxins Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Botulinum Toxins Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Botulinum Toxins Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Botulinum Toxins Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Botulinum Toxins Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Botulinum Toxins Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Botulinum Toxins Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Botulinum Toxins Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Botulinum Toxins Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Botulinum Toxins Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Botulinum Toxins Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Botulinum Toxins Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Botulinum Toxins Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Botulinum Toxins Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Botulinum Toxins Sales Volume, (2026-2031) & (K Units)
  • Table 57. AbbVie Company Information
  • Table 58. AbbVie Introduction and Business Overview
  • Table 59. AbbVie Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. AbbVie Botulinum Toxins Product Offerings
  • Table 61. AbbVie Recent Development
  • Table 62. Ipsen Company Information
  • Table 63. Ipsen Introduction and Business Overview
  • Table 64. Ipsen Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Ipsen Botulinum Toxins Product Offerings
  • Table 66. Ipsen Recent Development
  • Table 67. Medytox Company Information
  • Table 68. Medytox Introduction and Business Overview
  • Table 69. Medytox Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medytox Botulinum Toxins Product Offerings
  • Table 71. Medytox Recent Development
  • Table 72. LIBP Company Information
  • Table 73. LIBP Introduction and Business Overview
  • Table 74. LIBP Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. LIBP Botulinum Toxins Product Offerings
  • Table 76. LIBP Recent Development
  • Table 77. Merz Pharmaceuticals Company Information
  • Table 78. Merz Pharmaceuticals Introduction and Business Overview
  • Table 79. Merz Pharmaceuticals Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Merz Pharmaceuticals Botulinum Toxins Product Offerings
  • Table 81. Merz Pharmaceuticals Recent Development
  • Table 82. Hugel Company Information
  • Table 83. Hugel Introduction and Business Overview
  • Table 84. Hugel Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Hugel Botulinum Toxins Product Offerings
  • Table 86. Hugel Recent Development
  • Table 87. Daewoong Company Information
  • Table 88. Daewoong Introduction and Business Overview
  • Table 89. Daewoong Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Daewoong Botulinum Toxins Product Offerings
  • Table 91. Daewoong Recent Development
  • Table 92. US World Meds Company Information
  • Table 93. US World Meds Introduction and Business Overview
  • Table 94. US World Meds Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. US World Meds Botulinum Toxins Product Offerings
  • Table 96. US World Meds Recent Development
  • Table 97. Revance Company Information
  • Table 98. Revance Introduction and Business Overview
  • Table 99. Revance Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Revance Botulinum Toxins Product Offerings
  • Table 101. Revance Recent Development
  • Table 102. Galderma Company Information
  • Table 103. Galderma Introduction and Business Overview
  • Table 104. Galderma Botulinum Toxins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. Galderma Botulinum Toxins Product Offerings
  • Table 106. Galderma Recent Development
  • Table 107. Key Raw Materials Lists
  • Table 108. Raw Materials Key Suppliers Lists
  • Table 109. Botulinum Toxins Downstream Customers
  • Table 110. Botulinum Toxins Distributors List
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Botulinum Toxins Product Picture
  • Figure 2. Global Botulinum Toxins Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Botulinum Toxins Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Botulinum Toxins Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Botulinum Toxins Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Botulinum Toxins Report Years Considered
  • Figure 7. Global Botulinum Toxins Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Botulinum Toxins Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Botulinum Toxins Revenue in 2024
  • Figure 10. Botulinum Toxins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. 50IU/Vial Picture
  • Figure 12. 100IU/Vial Picture
  • Figure 13. Other Picture
  • Figure 14. Global Botulinum Toxins Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Botulinum Toxins Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Botulinum Toxins Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 17. Global Botulinum Toxins Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Botulinum Toxins Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Medical
  • Figure 20. Product Picture of Cosmetic
  • Figure 21. Global Botulinum Toxins Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Botulinum Toxins Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Botulinum Toxins Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Botulinum Toxins Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Botulinum Toxins Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Botulinum Toxins Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Botulinum Toxins Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Botulinum Toxins Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Botulinum Toxins Sales Volume (%), (2020-2031)
  • Figure 38. United States Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Botulinum Toxins Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Botulinum Toxins Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Botulinum Toxins Industrial Chain
  • Figure 60. Botulinum Toxins Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed